Aging with HIV: A practical review

Brazilian Journal of Infectious Diseases

Volumn 17, Issue 4, 2013, Pages 464-479

  Cardoso, Sandra Wagner ^a   Torres, Thiago Silva ^a   Santini Oliveira, Marilia ^a   Marins, Luana Monteiro Spindola ^a   Veloso, Valdiléa Gonçalves ^a   Grinsztejn, Beatriz ^a  

^a Funda??o Oswaldo Cruz   (Brazil)

Author keywords

Aging; AIDS; Brazil; Comorbidity; Elderly; HAART; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; CD27 ANTIGEN; CD28 ANTIGEN; NUCLEOSIDE DERIVATIVE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE; AGING; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; B LYMPHOCYTE; BONE MARROW SUPPRESSION; BONE MASS; CARDIOVASCULAR DISEASE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; COMORBIDITY; DISEASE ASSOCIATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSLIPIDEMIA; ENDOCRINE DISEASE; FOLLOW UP; FRAIL ELDERLY; GASTROINTESTINAL SYMPTOM; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INFECTION SENSITIVITY; KIDNEY DISEASE; KIDNEY FUNCTION; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; LIVER DISEASE; LYMPHOCYTE DEPLETION; LYMPHOCYTE FUNCTION; MALIGNANT NEOPLASTIC DISEASE; MEDICATION COMPLIANCE; MENOPAUSE; METABOLIC DISORDER; MITOCHONDRIAL TOXICITY; MORTALITY; NONHUMAN; OSTEOLYSIS; OXIDATIVE STRESS; PATIENT COMPLIANCE; PREVENTIVE HEALTH SERVICE; RESISTANCE TRAINING; SEXUAL BEHAVIOR; SHORT SURVEY; SMOKING; TELOMERE SHORTENING; TOXIC HEPATITIS; TREATMENT OUTCOME; TREATMENT PLANNING; VIRUS INHIBITION; VITAMIN D DEFICIENCY;

AGING; AIDS; BRAZIL; COMORBIDITY; ELDERLY; HAART; HIV;

ADULT; AGE FACTORS; AGED; AGING; ANTI-HIV AGENTS; BRAZIL; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HUMANS; LIFE EXPECTANCY; MIDDLE AGED; YOUNG ADULT;

EID: 84880950617     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2012.11.007     Document Type: Short Survey

References (96)

1. World Health Organization - WHO. Active ageing: a policy framework. Geneva; 2005. Available from: [accessed 26.07.12]. http://whqlibdoc.who.int/hq/2002/who_nmh_nph_02.8.pdf.
2. United Nations - UN. United Nations Department of Economic and Social Affairs. World population ageing 1950-2050. New York; 2002. Available from: [accessed 19.11.12]. http://www.un.org/esa/population/publications/worldageing19502050/.
3. Instituto Brasileiro de Geografia e Estatística - IBGE (Brazil). Perfil dos Idosos Responsáveis pelos Domicílios no Brasil 2000. Rio de Janeiro; 2002. Available from: [accessed 18.11.12]. http://www.ibge.gov.br/home/estatistica/populacao/perfilidoso/perfidosos2000.pdf.
4. Instituto Brasileiro de Geografia e Estatística - IBGE (Brazil). Síntese de Indicadores Sociais. Brasília; 2007. Available from: [accessed 26.07.12]. http://www.ibge.gov.br/home/estatistica/populacao/trabalhoerendimento/pnad2007/default.shtm.
5. Turra C.M., Rios Neto E. International accounting and economic consequences of aging in Brazil. Program and abstracts: XXVI USSP general population conference 2001.
6. Schmid G.P., Williams B.G., Garcia-Calleja J.M., et al. The unexplored story of HIV and ageing. Bull World Health Organ 2009, 87:162-A.
7. Lazarus J.V., Nielsen K.K. HIV and people over 50 years old in Europe. HIV Med 2010, 11:479-481.
8. Ministério da Saúde (Brazil). Secretaria de Vigilância em Saúde. Departamento de DST, AIDS e Hepatites virais. Boletim Epidemiológico - AIDS e DST 2011, Ministério da Saúde, Brasília, ano VIII, número 1.
9. Vance D.E. Aging with HIV: clinical considerations for an emerging population. Am J Nurs 2010, 110:42-47.
10. Bendavid E., Ford N., Mills E.J. HIV and Africa's elderly: the problems and possibilities. AIDS 2012, 26(Suppl. 1):S85-S91.
11. Centers for Disease Control - CDC (USA). Persons aged 50 and older. Available from: [accessed 03.08.12]. http://www.cdc.gov/hiv/topics/over50/index.htm.
12. Centers for Disease Control - CDC (USA) AIDS among persons aged > or = 50 years - United States, 1991-1996. MMWR Morb Mortal Wkly Rep 1998, 47:21-27.
13. Secretaria de Vigilância em Saúde. Departamento de DST, AIDS e Hepatites virais. Recomendações para Terapia Anti-retroviral em Adultos Infectados pelo HIV 2008, Ministério da Saúde (Brazil), Ministério da Saúde, Brasília, Available from: http://www.ensp.fiocruz.br/portal-ensp/judicializacao/pdfs/491.pdf [accessed 26.07.12].
14. Ministério de la Salud (Peru). Informe Nacional sobre los progresos realizados em la aplicación del UNGASS, período enero 2008 a diciembre 2009. Available from: [accessed 26.07.12]. http://www.unaids.org/en/regionscountries/countries/peru2009.
15. World Health Organization - WHO. Global HIV/AIDS response: epidemic update and health sector progress towards universe access. Genebra, Switzerland; 2011. Available from: [accessed 11.09.12]. http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/20111130_UA_Report_en.pdf.
16. Pollock M.L., Foster C., Knapp D., Rod J.L., Schmidt D.H. Effect of age and training on aerobic capacity and body composition of master athletes. J Appl Physiol 1987, 62:725-731.
17. Wolthers K.C., Bea G., Wisman A., et al. T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover. Science 1996, 274:1543-1547.
18. Strahl C., Blackburn E.H. The effects of nucleoside analogs on telomerase and telomeres in Tetrahymena. Nucleic Acids Res 1994, 22:893-900.
19. Justice A.C. HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep 2010, 7:69-76.
20. Haynes L. The effect of aging on cognate function and development of immune memory. Curr Opin Immunol 2005, 17:476-479.
21. Jiang W., Lederman M.M., Hunt P., et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 2009, 199:1177-1185.
22. Appay V., Fastenackels S., Katlama C., et al. Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients. AIDS 2011, 25:1813-1822.
23. Baker J.V., Peng G., Rapkin J., et al. CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS 2008, 22:841-848.
24. Monforte A., Abrams D., Pradier C., et al. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS 2008, 22:2143-2153.
25. Vasto S., Malavolta M., Pawelec G. Age and immunity. Immun Ageing 2006, 3:2.
26. Lindau S.T., Schumm L.P., Laumann E.O., Levinson W., O'Muircheartaigh C.A., Waite L.J. A study of sexuality and health among older adults in the United States. N Engl J Med 2007, 357:762-774.
27. Schick V., Herbenick D., Reece M., et al. Sexual behaviors, condom use, and sexual health of Americans over 50: implications for sexual health promotion for older adults. J Sex Med 2010, 7(Suppl. 5):315-329.
28. Elford J., Ibrahim F., Bukutu C., Anderson J. Over fifty and living with HIV in London. Sex Transm Infect 2008, 84:468-472.
29. Patel D., Gillespie B., Foxman B. Sexual behavior of older women: results of a random-digit-dialing survey of 2,000 women in the United States. Sex Transm Dis 2003, 30:216-220.
30. Coleman C.L., Ball K. Determinants of perceived barriers to condom use among HIV-infected middle-aged and older African-American men. J Adv Nurs 2007, 60:368-376.
31. Vance D.E., McGuinness T., Musgrove K., Orel N.A., Fazeli P.L. Successful aging and the epidemiology of HIV. Clin Interv Aging 2011, 6:181-192.
32. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008, 372:293-299. Collaboration ATC.
33. May M.T., Ingle S.M. Life expectancy of HIV-positive adults: a review. Sex Health 2011, 8:526-533.
34. Orchi N., Balzano R., Scognamiglio P., et al. Ageing with HIV: newly diagnosed older adults in Italy. AIDS Care 2008, 20:419-425.
35. Sanders G.D., Bayoumi A.M., Holodniy M., Owens D.K. Cost-effectiveness of HIV screening in patients older than 55 years of age. Ann Intern Med 2008, 148:889-903.
36. Abel T., Werner M. HIV risk behaviour of older persons. Eur J Public Health 2003, 13:350-352.
37. Zelenetz P.D., Epstein M.E. HIV in the elderly. AIDS Patient Care STDS 1998, 12:255.
38. Keller M.J., Hausdorff J.M., Kyne L., Wei J.Y. Is age a negative prognostic indicator in HIV infection or AIDS?. Aging (Milano) 1999, 11:35-38.
39. Vance D.E., Mugavero M., Willig J., Raper J.L., Saag M.S. Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life. J Assoc Nurses AIDS Care 2011, 22:17-25.
40. Centers for Disease Control - CDC (USA). HIV surveillance report. Available from: [accessed 11.08.11]. http://www.cdc.gov/hiv/surveillance/resources/reports/2008report/2008.
41. Grinsztejn B., Veloso V.G., Friedman R.K., et al. Early mortality and cause of deaths in patients using HAART in Brazil and the United States. AIDS 2009, 23:2107-2114.
42. Tumbarello M., Rabagliati R., de Gaetano Donati K., et al. Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy. BMC Infect Dis 2004, 4:46.
43. Wellons M.F., Sanders L., Edwards L.J., Bartlett J.A., Heald A.E., Schmader K.E. HIV infection: treatment outcomes in older and younger adults. J Am Geriatr Soc 2002, 50:603-607.
44. Greenbaum A.H., Wilson L.E., Keruly J.C., Moore R.D., Gebo K.A. Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals. AIDS 2008, 22:2331-2339.
45. Althoff K.N., Gebo K.A., Gange S.J., et al. CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?. AIDS Res Ther 2010, 7:45.
46. Silverberg M.J., Leyden W., Horberg M.A., DeLorenze G.N., Klein D., Quesenberry C.P. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med 2007, 167:684-691.
47. Gebo K.A. HIV infection in older people. BMJ 2009, 338:b1460.
48. Marzolini C., Back D., Weber R., et al. Ageing with HIV: medication use and risk for potential drug-drug interactions. J Antimicrob Chemother 2011, 66:2107-2111.
49. Cardoso S., Torres T., Veloso V., et al. Reasons for modifying the first HAART regimen among older patients in an urban HIV/AIDS cohort in Brazil (abstract A-240-0095-13457). Program and abstracts: XVIII international AIDS conference 2010 (Vienna) 2010.
50. Cordery D.V., Cooper D.A. Optimal antiretroviral therapy for aging. Sex Health 2011, 8:534-540.
51. Hinkin C.H., Hardy D.J., Mason K.I., et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS 2004, 18(Suppl. 1):S19-S25.
52. Colafigli M., Torti C., Trecarichi E.M., et al. Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. Clin Microbiol Infect 2012, 18:E299-E304.
53. Marzolini C., Elzi L., Gibbons S., et al. Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study. Antivir Ther 2010, 15:413-423.
54. Palella F.J., Baker R.K., Moorman A.C., et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006, 43:27-34.
55. Fisher M., Cooper V. HIV and ageing: premature ageing or premature conclusions?. Curr Opin Infect Dis 2012, 25:1-3.
56. Grulich A.E., Jin F., Poynten I.M., Vajdic C.M. HIV, cancer, and aging. Sex Health 2011, 8:521-525.
57. Reekie J., Kosa C., Engsig F., et al. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies. Cancer 2010, 116:5306-5315.
58. Crum-Cianflone N.F., Hullsiek K.H., Marconi V.C., et al. Anal cancers among HIV-infected persons: HAART is not slowing rising incidence. AIDS 2010, 24:535-543.
59. Desquilbet L., Margolick J.B., Fried L.P., et al. Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr 2009, 50:299-306.
60. Onen N.F., Overton E.T. A review of premature frailty in HIV-infected persons; another manifestation of HIV-related accelerated aging. Curr Aging Sci 2011, 4:33-41.
61. Kotler D.P. HIV and antiretroviral therapy: lipid abnormalities and associated cardiovascular risk in HIV-infected patients. J Acquir Immune Defic Syndr 2008, 49(Suppl. 2):S79-S85.
62. Triant V.A., Lee H., Hadigan C., Grinspoon S.K. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007, 92:2506-2512.
63. Kaplan R.C., Kingsley L.A., Gange S.J., et al. Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS 2008, 22:1615-1624.
64. Hasse B., Ledergerber B., Furrer H., et al. Morbidity and aging in HIV-infected persons: The Swiss HIV Cohort Study. Clin Infect Dis 2011, 53:1130-1139.
65. Friis-Moller N., Weber R., Reiss P., et al. Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study. AIDS 2003, 17:1179-1193.
66. Petoumenos K., Worm S.W. HIV infection, aging and cardiovascular disease: epidemiology and prevention. Sex Health 2011, 8:465-473.
67. Boufassa F., Dulioust A., Lascaux A.S., et al. Lipodystrophy in 685 HIV-1-treated patients: influence of antiretroviral treatment and immunovirological response. HIV Clin Trials 2001, 2:339-345.
68. Oursler K.K., Goulet J.L., Crystal S., et al. Association of age and comorbidity with physical function in HIV-infected and uninfected patients: results from the Veterans Aging Cohort Study. AIDS Patient Care STDS 2011, 25:13-20.
69. Phair J., Palella F. Renal disease in HIV-infected individuals. Curr Opin HIV AIDS 2011, 6:285-289.
70. Kearney F., Moore A.R., Donegan C.F., Lambert J. The ageing of HIV: implications for geriatric medicine. Age Ageing 2010, 39:536-541.
71. Valcour V., Paul R. HIV infection and dementia in older adults. Clin Infect Dis 2006, 42:1449-1454.
72. Benard A., Bonnet F., Tessier J.F., et al. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care STDS 2007, 21:458-468.
73. Van Den Bout-Van Den Beukel C.J., Fievez L., Michels M., et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008, 24:1375-1382.
74. de Luis D.A., Bachiller P., Aller R., et al. Relation among micronutrient intakes with CD4 count in HIV infected patients. Nutr Hosp 2002, 17:285-289.
75. Al-Harthi L., Voris J., Patterson B.K., et al. Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients. HIV Med 2004, 5:55-65.
76. Bolland M.J., Wang T.K., Grey A., Gamble G.D., Reid I.R. Stable bone density in HAART-treated individuals with HIV: a meta-analysis. J Clin Endocrinol Metab 2011, 96:2721-2731.
77. Mascolini M. Older women with HIV report "premature aging" strikingly more often than men. First International Workshop on HIV and Aging 2010.
78. de Pommerol M., Hessamfar M., Lawson-Ayayi S., et al. Menopause and HIV infection: age at onset and associated factors. ANRS CO3 Aquitaine cohort. Int J STD AIDS 2011, 22:67-72.
79. Yin M.T., Zhang C.A., McMahon D.J., et al. Higher Rates of Bone Loss in postmenopausal HIV-infected women: a longitudinal study. J Clin Endocrinol Metab 2012, 97:554-562.
80. Souza P.M., Jacob-Filho W., Santarem J.M., Zomignan A.A., Burattini M.N. Effect of progressive resistance exercise on strength evolution of elderly patients living with HIV compared to healthy controls. Clinics (Sao Paulo) 2011, 66:261-266.
81. Piggott D., Muzaale A., Mehta S., Brown T., Leng S., Kirk G. Frailty and incident hospitalization in a cohort of HIV-infected and uninfected injection drug users (IDUs). 2nd International Workshop on HIV and Aging 2011, Abstract O_06.
82. Onen N.F., Agbebi A., Shacham E., Stamm K.E., Onen A.R., Overton E.T. Frailty among HIV-infected persons in an urban outpatient care setting. J Infect 2009, 59:346-352.
83. Atta M.G., Deray G., Lucas G.M. Antiretroviral nephrotoxicities. Semin Nephrol 2008, 28:563-575.
84. Centers for Disease Control (CDC) Epidemiology and prevention of vaccine-preventable diseases 2012, Available in: http://www.cdc.gov/vaccines/pubs/pinkbook/index.html [accessed 03.08.12]. 12th ed.
85. Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia (Brazil). IV Diretriz Brasileira Sobre Dislipidemias e Prevenção da Aterosclerose. Available in: [accessed 06.08.12]. http://publicacoes.cardiol.br/consenso/2007/diretriz-DA.pdf.
86. European Aids Clinical Society. Available in: [accessed 23.04.12]. http://www.europeanaidsclinicalsociety.org/guidelinespdf/EACS-EuroGuidelines2009FullVersion.pdf.
87. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003, 139:137-147.
88. Lindeman R.D. Overview: renal physiology and pathophysiology of aging. Am J Kidney Dis 1990, 16:275-282.
89. Lotufo P.A. O escore de risco de Framingham para doenças cardiovasculares. Rev Med (São Paulo) 2008, 87:232-237.
90. Ministério da Saúde (Brasil). Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Manual dos Centros de Referência para Imunobiológicos Especiais. 3 Edição; 2006. Available in: [accessed 03.08.12]. http://portal.saude.gov.br/portal/arquivos/pdf/livro_cries_3ed.pdf.
91. Petoumenos K., Worm S.W. HIV infection, aging and cardiovascular disease: epidemiology and prevention. Sex Heath 2011, 8:465-473.
92. Post W.S. Predicting and preventing cardiovascular disease in HIV-infected patients. Top Antivir Med 2011, 19:169-173.
93. Röling J., Schmid H., Fischereder M., Draenert R., Goebel F.D. HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clin Infect Dis 2006, 42:1488-1495.
94. Sociedade Brasileira de Diabetes (Brasil). Diretrizes da sociedade brasileira de diabetes. Available in: [accessed 06.08.12]. http://www.diabetes.org.br/.
95. Tyerman Z., Aboulafia D.M. Review of screening guidelines for non-AIDS-defining malignancies: evolving issues in the era of highly active antiretroviral therapy. AIDS Rev 2012, 14:3-16.
96. Ministério da Saúde (Brazil). Secretaria de Vigilância em Saúde. Departamento de DST, AIDS e Hepatites virais. Boletim Epidemiológico - AIDS e DST. Brasília: Ministério da Saúde; ano VIII, número 1, 2011; Instituto Brasileiro de Geografia e Estatística (Brazil). Censo Demográfico; 2010. Available from: [accessed 03.11.11]. http://www.censo2010.ibge.gov.br/.